Special Report: ASX-listed medical tech firm HeraMED could be about to get a serious leg-up in the United States market by signing a letter of intent with virtual care provider eCare21.

As part of the LOI, HeraMED’s (ASX:HMD) HeraCARE platform, including the HeraBEAT fetal heartbeat monitor, will be integrated into the eCare21 care management platform.

eCare21 is a US-based patient-centric virtual care platform powered by Dell Technologies.

Its platform offers telehealth capabilities combined with remote patient monitoring into a single unified software-as-a-service (SaaS) solution. The company has laid claim to being the first end-to-end solution for virtual care that also creates a seamless workflow for delivering in-home healthcare.

HeraMED anticipates the newly integrated solution will simplify patient-centred virtual care for providers by offering a convenient solution to manage patients remotely and submit for insurance payment reimbursement.

The partnership news comes after HeraMED recently completed a milestone clinical study ahead of schedule of its HeraBEAT pregnancy monitoring technology.

Partnering with eCare21 offers validation for the efficacy and utility of the HeraCARE platform, which represents important progress for the company’s commercialisation strategy in the US.

HeraMED CEO and co-founder David Groberman said the partnership would allow the company to gain a foothold with a large number of healthcare providers already familiar with remote monitoring services.

“The integration of these complementary technological solutions will allow us to expand the accessibility of remote maternity monitoring. We’re committed to continuing to grow our solution to better serve patients and advance our mission to expand globally,” Groberman said.

eCare21 founder and CEO Vadim Cherdak added: “This is an exciting partnership to collaborate with HeraMED.

“The combined end-to-end solution provides a simplified and comprehensive end-to-end solution that enables remote patient monitoring to be deployed at scale. eCare21 combined with HeraMED’s unique pregnancy monitoring solutions creates the best-connected health solution on the market.”

The company also recently announced a collaboration with Mayo Clinic medical research as it continues development for its pre-natal health platform.

This article was developed in collaboration with HeraMED, a Stockhead advertiser at the time of publishing.

This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.

 

Read MoreTeleHealth

Featured Companies

You might be interested in